Form 6-K
DEF 14A
Teva Pharmaceutical Stock: Prepare For Takeoff (NYSE:TEVA) | Seeking Alpha
Teva - Smart Woman Securities
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Teva Reports Third Quarter 2020 Financial Results | Business Wire
Teva Pharmaceutical Industries Limited - AnnualReports.com
Teva Reports Second Quarter 2021 Financial Results | Business Wire
Teva Pharm Q3 profit misses estimates, sees recovery into Q4 | Reuters
Teva Pharmaceutical Industries Ltd 2019 Annual Report 10-K
TEVA: Teva Pharmaceutical Industries: Why Investors Should Buy the Dip
/cloudfront-us-east-2.images.arcpublishing.com/reuters/OTK6GU2XEBI7VCAOQV7BVCJQ4E.jpg "Teva Pharm expects U.S. opioid case settlements to cost $2.6 bln | Reuters")
Teva Pharm expects U.S. opioid case settlements to cost $2.6 bln | Reuters
Tear Sheet: Teva Pharmaceuticals Faces Pressure From Competing Generics, Seeks to Delever Quickly After Actavis Acquisition - Reorg
Teva Pharmaceuticals on Twitter: "Yesterday we shared Teva's business results for Q4 and full year 2021. Learn more here: https://t.co/ZWekP2kzJy #QuarterlyResults #Earnings $Teva Forward-looking statements are subject to the cautionary note included
Teva Reports Third Quarter 2021 Financial Results
TEVA 2022 Earnings Date, Forecast & Call Transcript (Teva Pharmaceutical Industries)
As U.S. Domestic Issuer, Teva Reveals Top Stock Owners | Ctech
Teva Continues To Be Oversold And Undervalued (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical Industries (NYSE:TEVA) Has No Shortage Of Debt | Nasdaq
Teva Reports First Quarter 2022 Financial Results
Teva Reports Fourth Quarter and Full Year 2021 Financial Results | Business Wire
Teva Pharmaceutical (TEVA) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow (NYSE:TEVA) | Seeking Alpha
Investors sue Teva over $41B Actavis deal - Drug Delivery Business
Teva climbs on report it is mulling 10,000 job cuts | Financial Times
